InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Anatol Kreitzer. Director active across 1 company, notably MapLight Therapeutics, Inc.. Cumulatively, 3 filings have been recorded. Activity tracked since 15 July 2026. The latest transaction was filed on 17 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations